KB
AGN

Kimelman & Baird’s Allergan plc AGN Stock Holding History

Kimelman & Baird’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-885
Closed -$204K – 125
2016
Q3 		$204K Buy
+885
New +$216K 0.04% 99
2016
Q2 		– Sell
-821
Closed -$220K – 108
2016
Q1 		$220K Hold
821
– – 0.04% 101
2015
Q4 		$257K Buy
+821
New +$244K 0.05% 92
2015
Q2 		$249K Buy
821
+85
+12% +$25.4K 0.04% 103
2015
Q1 		$219K Buy
+736
New +$210K 0.04% 104

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Kimelman & Baird's AGN Position: Q4 2016 in Review

Kimelman & Baird sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 885 shares — an estimated $204K sold.

Kimelman & Baird first reported a position in AGN in Q1 2015 and held it in 5 quarters. The position peaked at $257K in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Kimelman & Baird reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Kimelman & Baird sold 885 Allergan plc shares in Q4 2016, an estimated $204K.
  • Kimelman & Baird first reported a position in Allergan plc in Q1 2015 and held it in 5 quarters.
  • Kimelman & Baird's Allergan plc position peaked at $257K in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Kimelman & Baird's 13F filing for Q4 2016, filed 10 Apr 2017.